Depas and aspartate aminotransferase increased 
Depas and aspartate aminotransferase increased Patient Reports February 09, 2010
Depas Side Effects Report #5401131-X
Depas side effect was reported by a Consumer or non-health professional from JAPAN on July 24, 2007. Female patient, 53 years of age, was diagnosed with suicide attempt and was treated with Depas. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blister, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, coma, loss of consciousness, overdose, skin graft. Depas dosage: unknown. During the same period patient was treated with HALCION, LUDIOMIL. Patient was hospitalized. Patient recovered.
Depas Side Effects Report #5642338-6
Depas side effect was reported by a Pharmacist from JAPAN on Feb 20, 2008. Male patient, 78 years of age, was diagnosed with depression
, hypertension, gastric ulcer and was treated with Depas. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood bilirubin increased, blood calcium decreased, blood creatinine increased, blood culture positive, blood fibrinogen decreased, blood glucose increased, blood lactate dehydrogenase increased, blood pressure decreased. Depas dosage: 1 MG, UNK. During the same period patient was treated with DIOVAN, NORVASC, PAXIL, TAKEPRON. Patient was hospitalized. Patient died on 02/09/2008.Depas Side Effects Report #5650745-0
Depas side effect was reported by a Pharmacist from JAPAN on Feb 29, 2008. Male patient, 78 years of age, was diagnosed with depression
, hypertension, gastric ulcer and was treated with Depas. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood bilirubin increased, blood calcium decreased, blood creatinine increased, blood culture positive, blood fibrinogen decreased, blood glucose increased, blood lactate dehydrogenase increased, blood pressure decreased. Depas dosage: 1 MG, UNK. During the same period patient was treated with DIOVAN, NORVASC, PAXIL, TAKEPRON. Patient was hospitalized. Patient died on 02/09/2008.Depas Side Effects Report #5055978-2
Depas side effect was reported by a Physician from JAPAN on July 14, 2006. Male patient, 60 years of age, was treated with Depas. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, cardiac failure congestive, dysstasia, dysuria, gamma-glutamyltransferase abnormal, hepatitis fulminant. Depas dosage: unknown. During the same period patient was treated with LENDORMIN, MYSLEE, LOCHOL, ACINON, OLMETEC, CALBLOCK, FERROMIA, EBASTEL. Patient was hospitalized. Patient recovered.
Depas Side Effects Report #5078921-9
Depas side effect was reported by a Physician from JAPAN on July 14, 2006. Male patient, 60 years of age, was treated with Depas. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, cardiac failure congestive, dysstasia, dysuria, gamma-glutamyltransferase abnormal, hepatitis fulminant. Depas dosage: unknown. During the same period patient was treated with LENDORMIN, MYSLEE, LOCHOL, ACINON, OLMETEC, CALBLOCK, FERROMIA, EBASTEL. Patient was hospitalized. Patient recovered.
Depas Side Effects Report #5158239-6
Depas side effect was reported by a Consumer or non-health professional from JAPAN on Sept 27, 2006. Female patient, 51 years of age, weighting 178.6 lb, was diagnosed with neuralgia and was treated with Depas. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back pain
, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood urea increased, c-reactive protein increased, eosinophil count increased, gallbladder disorder. Depas dosage: 1.5 MG/DAY. During the same period patient was treated with WARFARIN, SELBEX, TEGRETOL. Patient was hospitalized. Patient recovered.